Literature DB >> 18480716

Normal motor development of Indian children on Peabody Developmental Motor Scales-2 (PDMS-2).

Ritesh Tripathi1, Abraham M Joshua, M Shashidhar Kotian, Jaya Shanker Tedla.   

Abstract

PURPOSE: To compare normal motor development scores of children in Mangalore, India, on the Peabody Developmental Motor Scales-2 (PDMS-2) with the normative scores provided with the instrument.
METHODS: The PDMS-2 were administered to 300 children from Mangalore, India, between birth and 60 months of age. Participants' scores were compared with those of the normative sample given in the PDMS-2 manual.
RESULTS: The Indian children's scores varied with some differing from the normative sample (p < 0.0001) whereas others did not differ across age groups and the different subtests of the PDMS-2.
CONCLUSIONS: It is not possible to develop assessment tools that are culturally sensitive across different geographical regions and environments, but it is necessary to evaluate the cultural sensitivity of such tests for use in a particular region and ethnic group, especially when these assessment tools are being used to diagnose and plan treatment for a child.

Entities:  

Mesh:

Year:  2008        PMID: 18480716     DOI: 10.1097/PEP.0b013e3181710340

Source DB:  PubMed          Journal:  Pediatr Phys Ther        ISSN: 0898-5669            Impact factor:   3.049


  2 in total

Review 1.  Movement skill assessment of typically developing preschool children: a review of seven movement skill assessment tools.

Authors:  Wouter Cools; Kristine De Martelaer; Christiane Samaey; Caroline Andries
Journal:  J Sports Sci Med       Date:  2009-06-01       Impact factor: 2.988

2.  Inter-rater reliability and test-retest reliability of the Performance and Fitness (PERF-FIT) test battery for children: a test for motor skill related fitness.

Authors:  Bouwien C M Smits-Engelsman; Eline Smit; Rosemary Xorlanyo Doe-Asinyo; Stella Elikplim Lawerteh; Wendy Aertssen; Gillian Ferguson; Dorothee L Jelsma
Journal:  BMC Pediatr       Date:  2021-03-11       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.